Advertisement

Cardiovascular medicine

Clinical case review

2018; 19(9): 54-55

Purpuric rash: is it meningococcal disease?

HASANTHA GUNASEKERA

2018; 19(8): 26-32

Genomics: what it means for patients and GPs

LISA EWANS, MARY-ANNE YOUNG

2018; 19(8): 14-24

Syncope: benign or sinister?

GAUTAM VADDADI

Drug update

2018; 19(6): 57-59

An update on lipid therapy with PCSK9 inhibitors

LEON A. SIMONS

2018; 19(6): 30-34

Haemangiomas. Treating those that won’t fade away

LIZ LEINS, David Orchard

2018; 19(6): 12-16

Heart murmur in a child. Is it innocent or pathological?

MATTHEW HENRY

Emergency medicine

2018; 19(5): 66-68

Holiday heart: mobile app suggests atrial fibrillation after ‘a few drinks’

Sascha Fulde, Gordian Fulde

2018; 19(3): 19-26

Heart failure: the crucial role of the GP

STEPHEN TOMLINSON, JOHN J. ATHERTON

Emergency medicine

2018; 19(2): 45-47

A routine ECG during a routine health check

Sascha Fulde, Gordian Fulde

2018; 19(2): 31-34

Chronic subdural haemorrhage. Untangling the complexities

Nicholas Little, Heath French

Cardiovascular medicine clinic

2017; 18(12): 58-60

Popliteal artery aneurysms

PATRIK TOSENOVSKY

2017; 18(12): 37-40

Hypertension: practical implications of the new National Heart Foundation guidelines

OMAR AZZAM, HAMISH PROSSER, Markus Schlaich

2017; 18(10): 33-38

Chronic venous insufficiency: the role of venous obstruction and treatment options

LAURENCIA VILLALBA

Dermatology clinic

2017; 18(9): 59-61

Refractory shallow ulcers on the lower leg

Victoria Harris, Gayle Fischer

2017; 18(9): 46-52

What’s the buzz around ‘lifestyle medicine’?

Garry Egger, HAMISH MELDRUM, Stephen Penman

2017; 18(9): 18-24

Stroke prevention: medical interventions for everyday practice

PATRICK SALVARIS, BRUCE CAMPBELL

2017; 18(8): 24-28

Secondary prevention after acute coronary syndromes: the GP’s role

SINJINI BISWAS, DION STUB, ANDREW E. AJANI

2017; 18(5): 33-40

Managing patients after implantation of a cardiac rhythm management device

HITESH C. PATEL, HARIHARAN RAJU, Alex Voskoboinik, JUSTIN A. MARIANI

2017; 18(2): 16-20

Cerebral aneurysms and subarachnoid haemorrhage: avoiding the diagnostic pitfalls

Nicholas Little, Heath French

2017; 18(1): 37-42

Heart failure with preserved ejection fraction: improving diagnosis and management

Shane Nanayakkara, Justin A Mariani, David M Kaye

2017; 18(1): 22-27

Managing lipid abnormalities in type 2 diabetes

Richard O'Brien

Drug update

2016; 17(12): 50-52

Sacubitril–valsartan: changing the paradigm for heart failure with reduced ejection fraction

Christopher Hayward

Drug update

2016; 17(11): 63-65

Idarucizumab: an anticoagulant reversal agent for dabigatran

Anthony FT Brown, Harshal Nandurkar

Drug update

2016; 17(10): 51-53

Alirocumab and evolocumab: a new era in cholesterol control

Leon A Simons

2016; 17(10): 25-28

How can we improve secondary prevention after ACS?

Tom Briffa, Clara Chow, Alexander Clark, Julie Redfern

Pages